USZ BioResource COVID-19

R

Regina Grossmann

Status

Terminated

Conditions

COVID19

Treatments

Other: blood sampling for biobank

Study type

Observational

Funder types

Other

Identifiers

NCT04414657
CTC HFV2

Details and patient eligibility

About

Mono-centric. Blood sampling for biobank development, including linkage to patient data (resource for research on COVID19).

Enrollment

150 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • m/f age > 18 years
  • SARS-CoV-2 infektion (according to WHO guideline)
  • hospitalisation, general ward
  • acceptable language knowledge
  • voluntary IFC and biobank appendix

Exclusion criteria

contra indication for blood sampling

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems